Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hidetaka Kurai"'
Autor:
Teruo Jojima, Hidetaka Kurai, Dai Tanuma, Hayato Kajitani, Masato Kase, Yuiko Inoue, Shintaro Sakurai, Toshie Iijima, Takuya Tomaru, Isao Usui, Yoshimasa Aso
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 41, Iss , Pp 101071- (2022)
Aims: To investigate synergistic effects of liver fibrosis evaluated by FibroScan and sarcopenia on endothelial function and arterial stiffness in patients with type 2 diabetes. Methods: This cross-sectional study evaluated liver fibrosis (LF) and sa
Externí odkaz:
https://doaj.org/article/2695e616ff0c468e812fe6f609a56b83
Publikováno v:
BMJ Case Reports; Jun2024, Vol. 17 Issue 6, p1-5, 5p
Autor:
Nanako Hirao, Toshie Iijima, Dai Tanuma, Eriko Ohira, Hidetaka Kurai, Toshimitsu Shinzawa, Masato Kase, Shintaro Sakurai, Takuya Tomaru, Teruo Jojima, Isao Usui, Yoshimasa Aso
Publikováno v:
Clinical Endocrinology. 97:841-848
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dce3fa9d5e955ae520aff04aa68ebab7
https://doi.org/10.1111/cen.14788
https://doi.org/10.1111/cen.14788
Autor:
Nanako, Hirao, Toshie, Iijima, Dai, Tanuma, Eriko, Ohira, Hidetaka, Kurai, Toshimitsu, Shinzawa, Masato, Kase, Shintaro, Sakurai, Takuya, Tomaru, Teruo, Jojima, Isao, Usui, Yoshimasa, Aso
Publikováno v:
Clinical endocrinologyREFERENCES. 97(6)
We investigated longitudinal changes in circulating CD4sup+/supand CD8sup+/supT cells positive for programed cell death protein-1 (PD-1) and in other subsets of CD4sup+/supT cells in untreated hyperthyroid patients with Graves' disease after treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b7bd26d239c67bd3380ebb1c7cf4bed1
https://pubmed.ncbi.nlm.nih.gov/35692119
https://pubmed.ncbi.nlm.nih.gov/35692119
Autor:
Teruo Jojima, Toshie Iijima, Soichiro Hosonuma, Takuya Tomaru, Yoshimasa Aso, Hayato Kanitani, Hidetaka Kurai, Isao Usui, Shintaro Sakurai
Aim: To investigate acute effects of add-on therapy with the sodium glucose co‐transporter 2 inhibitor tofogliflozin to dipeptidyl peptidase (DPP)-4 inhibitors on 24-hour glucose profile and glycemic variability evaluated by continuous glucose moni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd1eb0853c181735fd03540d5570296c
https://doi.org/10.22541/au.162260353.34823381/v1
https://doi.org/10.22541/au.162260353.34823381/v1
Autor:
Hidetaka Kurai, Shintaro Sakurai, Teruo Jojima, Isao Usui, Soichiro Hosonuma, Takuya Tomaru, Hayato Kajitani, Toshie Iijima, Yoshimasa Aso
Publikováno v:
International journal of clinical practiceREFERENCES. 75(11)
Aim To investigate acute effects of add-on therapy with the sodium glucose co-transporter 2 inhibitor tofogliflozin to dipeptidyl peptidase (DPP)-4 inhibitors on 24-hour glucose profile and glycemic variability evaluated by continuous glucose monitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca64b42b3f53c0d30ab2e90389f575af
https://pubmed.ncbi.nlm.nih.gov/34388297
https://pubmed.ncbi.nlm.nih.gov/34388297